FDA label
What is brivaracetam used for?
The FDA-approved uses of brivaracetam, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted brivaracetam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Brivaracetam, tablet, film coated
Indications and Usage, quoted from the label by ScieGen Pharmaceuticals, Inc. (ANDA219952). Cross-references to other label sections are left out.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Source: DailyMed label, set id bdbb6756-654c-46f1-a85c-7d5d1a89685a, version 1, effective July 23, 2026. NDC 50228-556, one of 39 listings for this product.
Questions
What is brivaracetam used for?
The FDA label says: “Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Brivaracetam
- Is Brivaracetam a controlled substance?Schedule V
- Generic for BriviactFDA Orange Book
- What is Briviact used for?FDA label uses
- Is Briviact a controlled substance?Schedule V
- Brivaracetam Medicare Part D coverageBy plan and state
- NDC 50474-370Brivaracetam NDC record
- NDC 50474-470Brivaracetam NDC record
- NDC 50474-570Brivaracetam NDC record
- Schedule V drugs listDEA schedule